These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38251257)
21. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Mondo K; Hammerschlag N; Basile M; Pablo J; Banack SA; Mash DC Mar Drugs; 2012 Feb; 10(2):509-520. PubMed ID: 22412816 [TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease-like neuropathology in three species of oceanic dolphin. Vacher MC; Durrant CS; Rose J; Hall AJ; Spires-Jones TL; Gunn-Moore F; Dagleish MP Eur J Neurosci; 2023 Apr; 57(7):1161-1179. PubMed ID: 36514861 [TBL] [Abstract][Full Text] [Related]
23. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Brand LE; Pablo J; Compton A; Hammerschlag N; Mash DC Harmful Algae; 2010 Sep; 9(6):620-635. PubMed ID: 21057660 [TBL] [Abstract][Full Text] [Related]
24. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures. Banack SA; Cox PA Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528 [TBL] [Abstract][Full Text] [Related]
25. TDP-43 Pathology in Alzheimer's Disease. Meneses A; Koga S; O'Leary J; Dickson DW; Bu G; Zhao N Mol Neurodegener; 2021 Dec; 16(1):84. PubMed ID: 34930382 [TBL] [Abstract][Full Text] [Related]
26. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732 [TBL] [Abstract][Full Text] [Related]
28. The Cyanotoxin and Non-protein Amino Acid β-Methylamino-L-Alanine (L-BMAA) in the Food Chain: Incorporation into Proteins and Its Impact on Human Health. Dunlop RA; Guillemin GJ Neurotox Res; 2019 Oct; 36(3):602-611. PubMed ID: 31377995 [TBL] [Abstract][Full Text] [Related]
29. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm. Papapetropoulos S Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249 [TBL] [Abstract][Full Text] [Related]
30. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease? Metcalf JS; Codd GA Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737 [TBL] [Abstract][Full Text] [Related]
31. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics. den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839 [TBL] [Abstract][Full Text] [Related]
32. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156 [TBL] [Abstract][Full Text] [Related]
33. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies. Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197 [TBL] [Abstract][Full Text] [Related]
34. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease. Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624 [TBL] [Abstract][Full Text] [Related]
35. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Murch SJ; Cox PA; Banack SA Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100 [TBL] [Abstract][Full Text] [Related]
36. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response. Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637 [TBL] [Abstract][Full Text] [Related]
37. Analysis of BMAA enantiomers in cycads, cyanobacteria, and mammals: in vivo formation and toxicity of D-BMAA. Metcalf JS; Lobner D; Banack SA; Cox GA; Nunn PB; Wyatt PB; Cox PA Amino Acids; 2017 Aug; 49(8):1427-1439. PubMed ID: 28620737 [TBL] [Abstract][Full Text] [Related]
38. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152 [TBL] [Abstract][Full Text] [Related]
39. Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background. Arezoumandan S; Cai X; Kalkarni P; Davis SA; Wilson K; Ferris CF; Cairns NJ; Gitcho MA Neurosci Lett; 2021 Jul; 758():136010. PubMed ID: 34090937 [TBL] [Abstract][Full Text] [Related]
40. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida. Banack SA; Metcalf JS; Bradley WG; Cox PA Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]